Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 32 h ago

GH Research PLC: RA CAPITAL MANAGEMENT, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

RA Capital Management, L.P. filed an amended Schedule 13G with the SEC (accession 0001346824-26-000281) updating its beneficial ownership stake in GH Research PLC. The amendment signals a change in the size of the healthcare-focused investor's position in the clinical-stage biotech, though the filing excerpt did not disclose the revised share count or percentage. The move matters because 13G amendments are closely watched for shifts in institutional backing of small-cap biotech names, where concentrated holders can influence governance and capital-raising dynamics. Investors will watch for the full filing details to confirm whether RA Capital increased, trimmed or maintained its stake, and for any subsequent 13D or Form 4 activity that would clarify intent.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

GH Research PLC, RA Capital Management, L.P.